Department of Medical Social Sciences, Medical University of South Carolina, South Carolina, USA
Mini Review
Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights
Author(s): Daniel Benny*
Esophageal carcinoma is a challenging malignancy with limited treatment options and poor prognosis, necessitating the exploration of novel
therapeutic strategies. Metformin, a widely used drug for type 2 diabetes, has shown promising anticancer effects in various malignancies,
including esophageal carcinoma. This article provides an overview of the molecular mechanisms underlying the anticancer properties of metformin
in esophageal carcinoma and discusses its therapeutic potential... Read More»
DOI:
10.37421/2475-3211.2024.9.247
Journal of Diabetic Complications & Medicine received 102 citations as per Google Scholar report